Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Neurology

How to Track Myasthenia Gravis Symptoms with MG-ADL

At a Glance

Track myasthenia gravis effectively by using the MG-ADL survey weekly and documenting symptoms when they are at their worst. Since MG symptoms fluctuate daily, sharing photos, voice memos, and a symptom journal with your neurologist ensures you get the right treatment adjustments.

Because myasthenia gravis (MG) symptoms fluctuate throughout the day, the best way to track them is by recording how you feel at your absolute worst, rather than just how you appear during a brief morning clinic visit. Experts recommend using a simple 8-question survey called the MG-ADL (Myasthenia Gravis Activities of Daily Living) to measure how the disease impacts your life over the past week [1][2]. Supplementing this weekly score with a daily journal, smartphone photos, and voice recordings provides your care team with a much more accurate picture of your disease than a standard doctor’s exam [3][4].

Understanding the MG-ADL Score

The MG-ADL (Myasthenia Gravis Activities of Daily Living) is a validated, 8-item questionnaire that measures how your symptoms affect everyday tasks [1][5]. Instead of relying on a doctor’s snapshot examination, this patient-reported tool asks you to rate your own functional limitations over the past 7 days [2][1]. You can easily find printable versions of the MG-ADL through major advocacy organizations like the Myasthenia Gravis Foundation of America (MGFA), or ask your neurologist for a copy.

The tool assesses tasks across several categories, assigning a score from 0 (normal) to 3 (severe) for each item, with a maximum possible total score of 24. For example, for chewing, a 0 means normal, a 1 means slight difficulty, and a 3 means you rely on a feeding tube.

  • Bulbar symptoms (affecting the mouth and throat): Talking, chewing, and swallowing.
  • Respiratory symptoms: Breathing limitations.
  • Gross motor tasks: Getting up from a chair, brushing teeth, or combing hair.
  • Ocular symptoms (affecting the eyes): Double vision and eyelid drooping.

A lower total score indicates less impact on your daily life. Clinical guidelines recommend tracking this score consistently to help doctors determine if your current medication is working [6][1]. Aiming for an MG-ADL score of 0 or 1—known as Minimal Symptom Expression (MSE)—is now recognized as an excellent and practical treatment goal [7][8].

Tracking Your “Worst” Moments (Diurnal Variation)

Myasthenia gravis is famous for diurnal variation, meaning symptoms change depending on the time of day and your activity level. You might wake up feeling strong, but experience severe muscle fatigue by the afternoon or after physical exertion.

Because of this fluctuation, snapshot assessments at the doctor’s office can be misleading [9][10]. If your doctor only sees you on a “good” morning, they may mistakenly believe your MG is perfectly controlled. While the formal MG-ADL asks you to reflect on the past week, you should also actively document the extremes of your daily fluctuations. Capturing your highest level of limitation ensures that your care team understands the full extent of your struggles and can adjust therapies accordingly [10][11].

Practical Tips for Home Tracking

Constantly focusing on and recording your “worst” moments can feel emotionally draining, but doing so provides vital evidence to get you the care you need. You do not need to take the 8-question MG-ADL every single day—doing it once a week is usually sufficient. To capture your daily variations efficiently:

  • Take Photos and Videos: Ptosis (drooping of the upper eyelid) and ocular muscle fatigue are easy to capture on camera. Take a photo or record a short video on your smartphone when your eyelid drooping or double vision is at its worst. This provides objective, quantitative data for your doctor [3][9].
  • Record Your Voice: If you experience voice changes or slurring (bulbar fatigue) after long conversations or at the end of the day, a quick voice memo on your phone serves as invaluable evidence.
  • Keep a Symptom and Medication Journal: Log the exact times you take your medication alongside when your symptoms spike. Because MG symptoms often worsen right before the next dose (a “wearing off” effect), this helps your neurologist adjust your dosage schedule.
  • Summarize for the Doctor: Doctors are busy, so presentation matters. Keep your tracking organized. Create a specific album on your phone for your MG photos and videos, and bring a concise list of your weekly MG-ADL scores to your appointment.
  • Be Consistent: Regular follow-up and active tracking on your part are strongly associated with better quality of life and improved symptom management [12]. Self-reported MG-ADL scores have a high level of agreement with physician evaluations, meaning your input is highly trusted and vital for your care [13].

Common questions in this guide

What is the MG-ADL score?
The MG-ADL is an 8-question survey that measures how myasthenia gravis symptoms affect your daily life. It assesses tasks across several categories, including talking, chewing, breathing, and getting up from a chair.
What is a good MG-ADL score?
A lower total score indicates less impact on your daily life. An MG-ADL score of 0 or 1 is known as Minimal Symptom Expression and is considered an excellent and practical treatment goal for myasthenia gravis patients.
Why do myasthenia gravis symptoms change throughout the day?
Myasthenia gravis is known for diurnal variation, meaning symptoms change depending on the time of day and your activity level. You might wake up feeling strong but experience severe muscle fatigue by the afternoon or after physical exertion.
How should I track my myasthenia gravis symptoms at home?
Experts recommend taking the MG-ADL survey once a week and actively documenting your worst symptom spikes daily. You can use smartphone photos of drooping eyelids, voice memos of slurred speech, and a daily medication journal to capture these fluctuations.
Why is it important to capture my worst myasthenia gravis symptoms?
Because symptoms fluctuate, a brief doctor's visit on a good morning might make your disease look perfectly controlled. Showing your doctor your worst moments ensures they understand your true limitations and can adjust therapies accordingly.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What target MG-ADL score should we be aiming for given my specific case, and what treatment adjustments will we make if I am not reaching it?
  2. 2.I often experience a 'wearing off' effect before my next medication dose; how should we adjust the timing of my medication based on my symptom journal?
  3. 3.How frequently would you like me to complete the MG-ADL questionnaire at home between our visits?
  4. 4.Would you prefer me to share my symptom photos and voice recordings during our appointment, or upload them to my patient portal beforehand?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Utilization of MG-ADL in myasthenia gravis clinical research and care.

    Muppidi S, Silvestri NJ, Tan R, et al.

    Muscle & nerve 2022; (65(6)):630-639 doi:10.1002/mus.27476.

    PMID: 34989427
  2. 2

    Psychometric properties of MG-ADL items and MG-ADL score: An assessment of distributional characteristics, validity and factor structure in two large datasets.

    Janssen MF, Dewilde S, Wolfe GI, et al.

    Journal of the neurological sciences 2024; (463()):123135 doi:10.1016/j.jns.2024.123135.

    PMID: 39068745
  3. 3

    Eye Segmentation Method for Telehealth: Application to the Myasthenia Gravis Physical Examination.

    Lesport Q, Joerger G, Kaminski HJ, et al.

    Sensors (Basel, Switzerland) 2023; (23(18)) doi:10.3390/s23187744.

    PMID: 37765800
  4. 4

    Telemedicine visits in myasthenia gravis: Expert guidance and the Myasthenia Gravis Core Exam (MG-CE).

    Guidon AC, Muppidi S, Nowak RJ, et al.

    Muscle & nerve 2021; (64(3)):270-276 doi:10.1002/mus.27260.

    PMID: 33959997
  5. 5

    Translation and validation of the Myasthenia Gravis Activities of Daily Living Questionnaire: Latvian version.

    Grosmane A, Roze I, Roddate M, et al.

    Frontiers in neurology 2024; (15()):1397603 doi:10.3389/fneur.2024.1397603.

    PMID: 38859974
  6. 6

    Expert consensus recommendations for improving and standardising the assessment of patients with generalised myasthenia gravis.

    Meisel A, Saccà F, Spillane J, et al.

    European journal of neurology 2024; (31(7)):e16280 doi:10.1111/ene.16280.

    PMID: 38523419
  7. 7

    The applicability of the myasthenia gravis patient registry data to disease burden and medication changes in clinical practice.

    Kushlaf H

    Muscle & nerve 2022; (66(4)):382-383 doi:10.1002/mus.27685.

    PMID: 35893079
  8. 8

    Minimal Symptom Expression in Generalized Myasthenia Gravis: A Valuable Patient-Centric Treatment Goal.

    Meisel A, Uzawa A, Qi CZ, et al.

    European journal of neurology 2026; (33(3)):e70563 doi:10.1111/ene.70563.

    PMID: 41853948
  9. 9

    A Digital Telehealth System to Compute the Myasthenia Gravis Core Examination Metrics.

    Garbey M, Joerger G, Lesport Q, et al.

    JMIR neurotechnology 2023; (2()) doi:10.2196/43387.

    PMID: 37435094
  10. 10

    Disease Severity Assessment and Short-Term Outcome in Patients with Myasthenia Gravis.

    Vemuri D, Garuda BR, Gopi S, et al.

    Annals of Indian Academy of Neurology 2020; (23(2)):215-219 doi:10.4103/aian.AIAN_243_19.

    PMID: 32189865
  11. 11

    Improvement in Patient-Reported Symptoms of Generalised Myasthenia Gravis With Rozanolixizumab in the Randomised Phase 3 MycarinG Study Using the MG Symptoms PRO.

    Kaminski HJ, Antozzi C, Habib AA, et al.

    European journal of neurology 2025; (32(8)):e70231 doi:10.1111/ene.70231.

    PMID: 40755069
  12. 12

    Diagnosis and therapy of myasthenia gravis-the patients' perspective: a cross-sectional study.

    Sobierajski T, Lasek-Bal A, Krzystanek M, Gilhus NE

    Frontiers in neurology 2023; (14()):1214041 doi:10.3389/fneur.2023.1214041.

    PMID: 37602258
  13. 13

    Concordance between patient- and physician-reported Myasthenia Gravis Activities of Daily Living (MG-ADL) scores.

    Dewilde S, Janssen MF, Tollenaar NH, et al.

    Muscle & nerve 2023; (68(1)):65-72 doi:10.1002/mus.27837.

    PMID: 37144893

This page provides educational information on tracking myasthenia gravis symptoms. Always consult your neurologist for personalized medical advice and treatment adjustments.

Get notified when new evidence is published on Myasthenia gravis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.